Vensica Medical
Tel Aviv, Israel· Est.
Israeli startup delivering needle‑free ultrasound‑mediated Botulinum toxin therapy for urology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $30M
AI Company Overview
Israeli startup delivering needle‑free ultrasound‑mediated Botulinum toxin therapy for urology.
Urology
Technology Platform
Vibe is a needle‑free ultrasound platform that creates cavitation bubbles to micro‑inject therapeutics directly into the bladder wall, enabling precise, localized drug delivery.
Opportunities
Scaling Vibe to additional bladder‑targeted biologics and expanding into other urology indications could unlock multi‑billion‑dollar market opportunities.
Risk Factors
Regulatory approval for a combination device‑drug product and adoption by clinicians accustomed to needle‑based injections present significant hurdles.
Competitive Landscape
Key competitors include traditional intradetral Botox injections and neuromodulation devices; Vensica differentiates through needle‑free, ultrasound‑mediated delivery that promises better patient comfort and dosing precision.